Task Force on Genetic Nomenclature in Movement Disorders

 

         
Christine Klein         Connie Marras
Chair                              Co-Chair

MDS Staff Liaison: Shazia Ali

Task Force Purpose
The purpose of this task force is to provide recommendations for revising the current nomenclature for genetically determined movement disorders in order to resolve or minimize problems that are sources of confusion and perpetuate misinformation.

Task Force Members              

  • Darius Ebrahimi-Fakhari
  • Vladimir Kostic
  • Anthony Lang
  • Christina Lill
  • Katja Lohman
  • Carolyn Sue
  • Sara Tabrizi
  • Marina de Koning-Tijssen
  • Tom Warner
  • Bart Van de Warrenburg
     

Task Force Publications and Resources

Revision to Nomenclature of Genetically Determined Movement Disorders

A paper describing our proposed revision to the nomenclature of genetically determined movement disorders was published in the April 2016 issue of Movement Disorders. The lists of these entities is contained in the paper and are updated periodically.

Updates to the original lists can be found below:


Last Updated: April 2018

Thank you for your feedback
Prior to submission we solicited feedback from MDS members on our proposal and many thoughtful comments were gratefully received.  Many ideas were incorporated into the paper, and responses of the Task Force to the comments are summarized here.

Other Publications

Genotype‐Phenotype Relations for the Parkinson's Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review

Authors: Kasten M, Hartmann C, Hampf J, SchaakeS, Westenberger A, Vollstedt E, Balck A, Domingo A, Vulinovic F, Dulovic M, Zorn I, Madoev H, Zehnle H, Lembeck CM, Schawe L, Reginold J, Huang J, König IR, Bertram L, Marras C, Lohmann K, Lill CM, Klein C
(April 2017) Movement Disorders

The genetic nomenclature of recessive cerebellar ataxias

Authors: Rossi M, Anheim M, Durr A, Klein C, Koenig M, Synofzik M, Marras C, van de Warrenburg BP
(May 2018) Movement Disorders

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice